Recently, Cogle et al have shown that the increase in the number of CD34+ cells in bone marrow is directly associated with improved functional outcomes after acute myocardial infarction (AMI) in the Timing in Myocardial Infarction Evaluation (TIME) and Late TIME clinical trials [35]. The gene discussed is CD34; the disease is acute myocardial infarction.